Micro/nanotopographies (MNTs) have been reported to enhance
the
osseointegration of biomaterials and modulate cell functions, but
the underlying mechanisms are incompletely understood. We hypothesized
that transient receptor potential vanilloid 4 (TRPV4) may mediate
the topographically induced osteoblastic differentiation of bone marrow
stem cells (BMSCs) by regulating the NFATc1 and Wnt/β-catenin
signaling. To test this hypothesis, murine BMSCs were cultured on
polished titanium (Ti) discs (PT) and Ti discs carrying titania nanotubes
(i.e., MNTs) with diameters of ∼30 and ∼100 nm (termed
TNT-30 and TNT-100, respectively). It was found that the MNTs (in
particular TNT-100) promoted the expression and activation of TRPV4.
Inhibition of TRPV4 in BMSCs cultured on TNT-100 reduced the expression
of osteoblastic genes and the gene expression and protein levels of
NFATc1 and Wnt3a/β-catenin and also decreased nuclear translocation
of NFATc1 and β-catenin (all vs uninhibited BMSCs). Conversely,
activation of TRPV4 in BMSCs cultured on PT increased the expression
of the osteoblastic gene and the gene expression and protein level
of NFATc1 and Wnt3a/β-catenin and also enhanced the nuclear
translocation of NFATc1 and β-catenin (all vs unactivated BMSCs).
These differences suggest that the MNTs promoted TRPV4 expression
and activation to enhance intracellular Ca2+, which further
increased the nuclear translocation of NFATc1 and stimulated the Wnt/β-catenin
signaling, thus leading to upregulated expression of osteoblastic
genes. These results indicate TRPV4 to be a mediator in MNT-induced
osteoblastic differentiation of BMSCs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.